This brand name is authorized in Albania, Brazil, Cyprus, Ecuador, Estonia, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, Poland, Singapore, Tunisia, Turkey, South Africa
The drug CATAFLAM contains one active pharmaceutical ingredient (API):
|
1
Diclofenac
UNII L4D5UA6CB4 - DICLOFENAC POTASSIUM
|
|
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| CATAFLAM Sugar coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M01AB05 | Diclofenac | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AL | Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor | Identifier(s): 219/92a |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 526502704115318, 526502708171311, 526502709117319, 526502713114310 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 1550-MEE-1215, 27.898-12-07, 367050813, 367110813 |
| Country: EE | Ravimiamet | Identifier(s): 1002520, 1737503 |
| Country: HK | Department of Health Drug Office | Identifier(s): 35993, 35994 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 16286 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 3156 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1000418 |
| Country: MT | Medicines Authority | Identifier(s): MA1249/00201, MA1249/00202, PI1438/01901A, PI521/04001B, PI770/09701A, PI908/00701C |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 016M98, 064M90, 071M86, 074M84 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 29904 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100013100, 100063664, 100204700, 100287582, 100296078, 100304406, 100357934, 100396503, 100397514, 100443533, 100466114 |
| Country: SG | Health Sciences Authority | Identifier(s): 05664P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9253671, 9253672 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699504120097 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): A39/3.1/0588 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
